DLFClass II
Enzyme Immunoassay, Ethosuximide
21 CFR 862.3380 / Clinical Toxicology
DLF is the FDA product code for Enzyme Immunoassay, Ethosuximide, a class II device type, regulated under 21 CFR 862.3380. As of , FDA records hold 9 510(k) clearances under this code, the most recent dated , and no recalls.
Classification record
- Product code
- DLF
- Device name
- Enzyme Immunoassay, Ethosuximide
- Regulation
- 21 CFR 862.3380
- Device class
- Class II
- Review panel
- Clinical Toxicology
- Submission type
- 510(k)
- Implant
- No
- Life sustaining or supporting
- No
- GMP exempt
- No
- Third party review eligible
- Yes
- Ingested clearances
- 9
- Ingested recalls
- 0
Clearances, product code DLF
By decision yearShow the numbers
| Year | Clearances |
|---|---|
| 1978 | 2 |
| 1979 | 1 |
| 1983 | 3 |
| 1984 | 1 |
| 1985 | 1 |
| 1988 | 1 |
Applicants with the most clearances
Product code DLF| Applicant | Clearances |
|---|---|
| Syva Co. | 4 |
| Abbott Medical | 1 |
| E.I. Dupont de Nemours & Co., Inc. | 1 |
| Em Diagnostic Systems, Inc. | 1 |
| Miles Laboratories, Inc. | 1 |
| Syva Co. | 1 |
Companies listing this code with FDA
Companies whose registered establishments list this codeFIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
